机器学习因果森林分析:冠状动脉旁路移植术在缺血性心肌病中的异质性治疗效应
基于外科治疗缺血性心力衰竭试验的1212例患者,采用机器学习因果森林建模分析冠状动脉旁路移植术与单纯药物治疗的异质性治疗效应。左心室收缩末期容积指数、血清肌酐和年龄可区分治疗效应异质性;左心室收缩末期容积指数大于84 mL/m2且年龄60.27岁及以下的患者,冠状动脉旁路移植术与全因死亡和心血管死亡风险显著降低相关。
要点
- 机器学习因果森林识别出左心室收缩末期容积指数、血清肌酐和年龄为治疗效应异质性因素。
- 左心室收缩末期容积指数大于84 mL/m2且年龄60.27岁及以下者,冠状动脉旁路移植术与全因死亡风险降低相关(校正HR 0.61,95%CI 0.45-0.84)。
- 左心室收缩末期容积指数84 mL/m2及以下且血清肌酐1.04 mg/dL及以下者,或左心室收缩末期容积指数大于84 mL/m2且年龄大于60.27岁者,冠状动脉旁路移植术的生存获益不再存在。
核心结论
- 本事后分析发现缺血性心肌病患者中冠状动脉旁路移植术存在异质性治疗效应。
- 较年轻且左心室严重扩大的患者更可能从冠状动脉旁路移植术获得更大的生存获益。
研究设计与样本
- 基于外科治疗缺血性心力衰竭试验的1212例患者的事后分析,采用机器学习因果森林建模评估冠状动脉旁路移植术与单纯药物治疗的异质性治疗效应。
主要发现
- 左心室收缩末期容积指数大于84 mL/m2且年龄60.27岁及以下者,冠状动脉旁路移植术与全因死亡风险显著降低相关(校正HR 0.61,95%CI 0.45-0.84)。
- 左心室收缩末期容积指数大于84 mL/m2且年龄60.27岁及以下者,冠状动脉旁路移植术与心血管死亡风险显著降低相关(校正HR 0.63,95%CI 0.45-0.89)。
- 左心室收缩末期容积指数84 mL/m2及以下且血清肌酐1.04 mg/dL及以下者,或左心室收缩末期容积指数大于84 mL/m2且年龄大于60.27岁者,冠状动脉旁路移植术的生存获益不再存在。
关键数值与推荐
- 机器学习算法识别出左心室收缩末期容积指数、血清肌酐和年龄可区分治疗效应异质性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aim to evaluate the heterogeneous treatment effects of coronary artery bypass grafting in patients with ischemic cardiomyopathy and to identify a group of patients to have greater benefits from coronary artery bypass grafting compared with medical therapy alone. METHODS: Machine learning causal forest modeling was performed to identify the heterogeneous treatment effects of coronary artery bypass grafting in patients with ischemic cardiomyopathy from the Surgical Treatment for Ischemic Heart Failure trial. The risks of death from any cause and death from cardiovascular causes between coronary artery bypass grafting and medical therapy alone were assessed in the identified subgroups. RESULTS: Among 1212 patients enrolled in the Surgical Treatment for Ischemic Heart Failure trial, left ventricular end-systolic volume index, serum creatinine, and age were identified by the machine learning algorithm to distinguish patients with heterogeneous treatment effects. Among patients with left ventricular end-systolic volume index greater than 84 mL/m2 and age 60.27 years or less, coronary artery bypass grafting was associated with a significantly lower risk of death from any cause (adjusted hazard ratio, 0.61; 95% CI, 0.45-0.84) and death from cardiovascular causes (adjusted hazard ratio, 0.63; 95% CI, 0.45-0.89). By contrast, the survival benefits of coronary artery bypass grafting no longer exist in patients with left ventricular end-systolic volume index 84 mL/m2 or less and serum creatinine 1.04 mg/dL or less, or patients with left ventricular end-systolic volume index greater than 84 mL/m2 and age more than 60.27 years. CONCLUSIONS: The current post hoc analysis of the Surgical Treatment for Ischemic Heart Failure trial identified heterogeneous treatment effects of coronary artery bypass grafting in patients with ischemic cardiomyopathy. Younger patients with severe left ventricular enlargement were more likely to derive greater survival benefits from coronary artery bypass grafting.
引用
- Zhou Z, Jian B, Chen X, et al. Heterogeneous treatment effects of coronary artery bypass grafting in ischemic cardiomyopathy: A machine learning causal forest analysis. J Thorac Cardiovasc Surg. 2023. PMID: 37716652. doi:10.1016/j.jtcvs.2023.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。